Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13514-79-9

Post Buying Request

13514-79-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13514-79-9 Usage

Description

6-METHYL-2-PHENYL-4(1H)PYRIMIDINONE is a chemical compound belonging to the pyrimidinone family, characterized by a molecular formula of C11H10N2O and a molecular weight of 186.21 g/mol. It features a pyrimidine ring with a methyl and phenyl group attached, serving as a versatile building block in the synthesis of pharmaceuticals, agrochemicals, and dyes.

Uses

Used in Pharmaceutical Industry:
6-METHYL-2-PHENYL-4(1H)PYRIMIDINONE is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new chemical entities with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 6-METHYL-2-PHENYL-4(1H)PYRIMIDINONE is utilized as a precursor in the production of agrochemicals, aiding in the creation of compounds that can enhance crop protection and yield.
Used in Dye Industry:
6-METHYL-2-PHENYL-4(1H)PYRIMIDINONE is employed as a building block in the synthesis of dyes, contributing to the development of novel colorants for various applications, including textiles, plastics, and printing inks.

Check Digit Verification of cas no

The CAS Registry Mumber 13514-79-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,5,1 and 4 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 13514-79:
(7*1)+(6*3)+(5*5)+(4*1)+(3*4)+(2*7)+(1*9)=89
89 % 10 = 9
So 13514-79-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H10N2O/c1-8-7-10(14)13-11(12-8)9-5-3-2-4-6-9/h2-7H,1H3,(H,12,13,14)

13514-79-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-methyl-2-phenyl-1H-pyrimidin-4-one

1.2 Other means of identification

Product number -
Other names 6-methyl-2-phenyl-4-pyrimidinol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13514-79-9 SDS

13514-79-9Relevant articles and documents

Sugiyama et al.

, p. 296 (1972)

Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 Antagonists

Silbermann, Katja,Li, Jiyang,Namasivayam, Vigneshwaran,Baltes, Fabian,Bendas, Gerd,Stefan, Sven Marcel,Wiese, Michael

, p. 10412 - 10432 (2020/11/02)

In the search for highly effective modulators addressing ABCG2-mediated MDR, 23 pyrimidines were synthesized and biologically assessed. Seven derivatives with (a) nitrogen- and/or halogen-containing residue(s) had extraordinary potencies against ABCG2 (IC50 150 nM). The compounds competitively inhibited ABCG2-mediated Hoechst 33342 transport but were not substrates of ABCG2. The most potent MDR reverser, compound 19, concentration-dependently increased SN-38-mediated cancer cell death at 11 nM (EC50), time-dependently doubled SN-38 toxicity in a period of 7 days at 10 nM, and half-maximally accelerated cell death combined with SN-38 at 17 nM. No induction of ABCG2 was observed. Furthermore, 11 pyrimidines were revealed as triple ABCB1/ABCC1/ABCG2 inhibitors. Five possessed IC50 values below 10 μM against each transporter, classifying them as some of the 50 most potent multitarget ABC transporter inhibitors. The most promising representative, compound 37, reversed ABCB1-, ABCC1-, and ABCG2-mediated MDR, making it one of the three most potent ABC transporter inhibitors and reversers of ABC transporters-mediated MDR.

NURR1:RXR ACTIVATING COMPOUNDS FOR SIMULTANEOUS TREATMENT OF SYMPTOMS AND PATHOLOGY OF PARKINSON'S DISEASE

-

Page/Page column 37; 41, (2017/08/01)

The invention provides a series of substituted aryl pyrimidine compounds and the use of these compounds as therapeutics to treat or prevent neurodegenerative disorders, including Parkinson's disease. Compounds of the invention are also able to treat the s

Pyrimidine derivatives and application thereof

-

Paragraph 0091-0093; 0110-0112, (2016/10/20)

The invention discloses compounds of formula (1), and pharmaceutically acceptable salts thereof, and an application of the compounds and the pharmaceutically acceptable salts in prevention and treatment of aches.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13514-79-9